Company page

Iradimed Corporation

Iradimed Corporation, traded under the ticker IRMD, operates in the American market with a market capitalization of approximately $1.16 billion. The company specializes in innovative medical technologies, particularly in the field of MRI-compatible intravenous infusion systems. Iradimed is focused on enhancing patient safety and improving the efficiency of medical procedures.